Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R): A biomedical product used for targeted delivery of therapeutics to the central nervous system. Employing a modified Rabies Virus Glycoprotein, it enables selective transport across the blood-brain barrier. Findings suggest its potential in treating neurodegenerative disorders, such as Alzheimer's or Parkinson's disease.
CAT# | GR2207 |
CAS | 1678417-57-6 |
M.F/Formula | C201H334N82O55S2 |
M.W/Mr. | 4843.45 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Linaclotide, sold under the brand name Linzess, is a synthetic tetradecapeptide and guanylate cyclase (GC-C) rec ...
The peptide st-Ht31 P, A-kinase anchoring protein (AKAP) inhibitor, has the negative control for st-Ht31. In DRG ...
The toxin BeKm 1 is a HERG-specific peptide toxin, which are voltage-gated K+ channels, coded by the human ether ...
ProTx II, a 30-amino acid, disulfide-rich peptide toxin, isolated from the venom of the tarantula, Thrixopelma ...
GsMTx4 is a synthetic and biologically active peptide toxin. Its molecular formula is C185H273N49O45S6, with the ...